Moneycontrol
HomeNewsIndiaCovid is here to stay; no need to panic but take precautions, says PHFI’s Dr K Srinath Reddy
Trending Topics

Covid is here to stay; no need to panic but take precautions, says PHFI’s Dr K Srinath Reddy

Hybrid immunity, through vaccines and exposure to the virus, is likely to protect people but they still need to follow Covid appropriate behaviour, says the health expert

June 03, 2025 / 16:01 IST
Story continues below Advertisement

India needs to go back to following Covid-era precautions

Covid infections are rising in the country again, so is the panic. India’s active case count now tops 4,000 and 37 people, with co-morbidities, have succumbed to the coronavirus this season.

How serious is this outbreak? How infectious are JN.1 and the LF.7 and NB.1.8 strains of Omicron, which are causing the infections? Is it time for another round of vaccines? Should the government start tracking the infected and their contacts? What about masks?

Story continues below Advertisement

Dr K Srinath Reddy, founder-president of the Public Health Foundation of India (PHFI), answers all these questions and more in an interview to Moneycontrol. Here are the edited excerpts of the interview:

Do we need to worry about the rising Covid cases in the country?

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show